Thromb Haemost 2005; 93(02): 394-395
DOI: 10.1055/s-0037-1616249
Letters to the Editor
Schattauer GmbH

Coagulation factor XIII B subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians

Kirti Kain
1   Leeds University, Academic Unit of Molecular Vascular Medicine, Leeds, West Yorkshire, United Kingdom
,
John Young
1   Leeds University, Academic Unit of Molecular Vascular Medicine, Leeds, West Yorkshire, United Kingdom
,
John Bavington
1   Leeds University, Academic Unit of Molecular Vascular Medicine, Leeds, West Yorkshire, United Kingdom
,
John Bamford
1   Leeds University, Academic Unit of Molecular Vascular Medicine, Leeds, West Yorkshire, United Kingdom
,
Andrew J. Catto
1   Leeds University, Academic Unit of Molecular Vascular Medicine, Leeds, West Yorkshire, United Kingdom
› Author Affiliations
Financial support: The Stroke Association funded the study.
Further Information

Publication History

Received 20 August 2004

Accepted after resubmission 25 November 2004

Publication Date:
14 December 2017 (online)

 

 
  • References

  • 1 Mansfield MW, Kohler HP, Ariens RA. et al Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.. Diabetes Care 2000; 23: 703-5.
  • 2 Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.. Thromb Haemost 2001; 85: 408-11.
  • 3 Kain K, Catto AJ, Young J. et al Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.. Atherosclerosis 2002; 163: 371-6.
  • 4 Catto AJ, Kohler HP, Coore J. et al Association of a common polymorphism in the factor XIII gene with venous thrombosis.. Blood 1999; 93: 906-8.
  • 5 Pyorala M, Miettinen H, Halonen P. et al Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.. Arterioscler Thromb Vasc Biol 1999; 20: 538-44.
  • 6 Kain K, Catto AJ, Grant PJ. Clustering of thrombotic factors with insulin resistance in South asian patients with ischaemic stroke.. Thromb Haemost 2002; 88: 950-3.
  • 7 Reiner AP, Frank MB, Schwartz SM. et al Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.. Br J Haematol 2002; 116: 376-82.
  • 8 Endler G, Funk M, Haering D. et al Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?. Br J Haematol 2003; 120: 310-4.
  • 9 Corral J, Gonzalez-Conejero R, Iniesta JA. et al The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.. Haematologica 2000; 85: 293-7.
  • 10 Gemmati D, Serino ML, Ongaro A. et al A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.. Am J Hematol 2001; 67: 183-8.
  • 11 Kohler HP, Stickland MH, Ossei-Gerning N. et al Association of a common polymorphism in the factor XIII gene with myocardial infarction.. Thromb Haemost 1998; 79: 8-13.
  • 12 Elbaz A, Poirier O, Canaple S. et al The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.. Blood 2000; 95: 586-9.